Guardant Health Inc (GH)

Apr 21, 2025

RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know - Yahoo

Apr 21, 2025

Apr 21, 2025

3 Reasons to Sell GH and 1 Stock to Buy Instead - Yahoo Finance

Apr 21, 2025

Apr 15, 2025

Guardant Health price target raised to $60 from $56 at BofA - Yahoo Finance

Apr 15, 2025

Apr 14, 2025

Guardant Health (GH) Price Target Increased by BofA Amid Sector Challenges | GH Stock News - GuruFocus

Apr 14, 2025

Apr 14, 2025

BofA Securities Raises Price Target on Guardant Health to $60 From $56, Keeps Buy Rating - marketscreener.com

Apr 14, 2025

Apr 12, 2025

Lobbying Update: $15,500 of GUARDANT HEALTH INC. lobbying was just disclosed - Quiver Quantitative

Apr 12, 2025

Apr 11, 2025

Guardant Health to Report First Quarter 2025 Financial Results o - GuruFocus

Apr 11, 2025

Apr 11, 2025

Circulating Cell-Free Tumor DNA Market Detailed In New Research - openPR.com

Apr 11, 2025

Apr 11, 2025

S&P 500 Futures Up in Premarket Trading; Guardant Health, Brookfield Wealth Solns Lead - Barron's

Apr 11, 2025

Apr 10, 2025

Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025 - The Joplin Globe

Apr 10, 2025

Apr 10, 2025

Mizuho Initiates Coverage of Guardant Health (GH) with Outperform Recommendation - MSN

Apr 10, 2025

Apr 10, 2025

Barclays Adjusts Guardant Health (GH) Price Target Amid Sector C - GuruFocus

Apr 10, 2025

Apr 10, 2025

Mizuho Initiates Guardant Health at Outperform - marketscreener.com

Apr 10, 2025

Apr 10, 2025

Guardant Health secures facility lease extension through 2031 By Investing.com - Investing.com Canada

Apr 10, 2025

Apr 09, 2025

‘Preparing For Regulatory Milestones, Commercial Launch’ Are Priorities, Says New Freenome CEO Aaron Elliott - insights.citeline.com

Apr 09, 2025

Apr 09, 2025

Guardant Health (GH) Receives Outperform Rating from Mizuho with Strong Growth Prospects | GH Stock News - GuruFocus

Apr 09, 2025

Apr 09, 2025

Guardant Health secures facility lease extension through 2031 - Investing.com

Apr 09, 2025

Apr 08, 2025

Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH) - Yahoo Finance

Apr 08, 2025

Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025

Apr 03, 2025

Guardant Health partners with Bayshore for cancer tests in Canada By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada - 01net

Apr 03, 2025

Apr 03, 2025

Guardant Health partners with Bayshore for cancer tests in Canada - Investing.com

Apr 03, 2025

Apr 03, 2025

Guardant Health And Bayshore Healthcare Partner To Expand Access To Advanced Precision Oncology Testing In Canada - MarketScreener

Apr 03, 2025

Apr 01, 2025

A More Convenient Way to Get Screened for Colon Cancer - Sunnyside Sun

Apr 01, 2025

Mar 31, 2025

(GH) Trading Advice - news.stocktradersdaily.com

Mar 31, 2025

Mar 29, 2025

4 Healthcare Stocks With Massive Gains—and More to Come - MarketBeat

Mar 29, 2025

Mar 27, 2025

Guardant Health’s Strategic Growth: Shield’s Coverage Expansion and Revenue Potential - TipRanks

Mar 27, 2025

Mar 26, 2025

Clinical Applications of ctDNA in Colorectal Cancer: Where Do We Stand? - ASCO Daily News

Mar 26, 2025

Mar 26, 2025

Liquid Biopsy Market Insights and Projections 2025-2032 - openPR

Mar 26, 2025

Mar 25, 2025

VA expands coverage to include CRC blood test for veterans By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

VA expands coverage to include CRC blood test for veterans - Investing.com India

Mar 25, 2025

Mar 25, 2025

Guardant Health shares rise on VA coverage for cancer test By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

Guardant Health shares rise on VA coverage for cancer test - Investing.com

Mar 25, 2025

Mar 25, 2025

Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries - Yahoo Finance

Mar 25, 2025

Mar 25, 2025

Key Market Driver in Breast Cancer Liquid Biopsy Industry 2025: Rising Breast Cancer Cases Fuel Demand For ... - WhaTech

Mar 25, 2025

Mar 21, 2025

Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN

Mar 21, 2025

Mar 20, 2025

Guardant Health director Tariq Musa sells $5,069 in stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Guardant Health director Tariq Musa sells $5,069 in stock - Investing.com India

Mar 20, 2025

Mar 20, 2025

1 Healthcare Stock on Our Watchlist and 2 to Turn Down - Yahoo Finance

Mar 20, 2025

Mar 18, 2025

AI Healthcare Co. Accuses Test-Maker Of Infringing Patents - Law360

Mar 18, 2025

Mar 18, 2025

AI Health Care Co. Accuses Test-Maker Of Infringing Patents - Law360

Mar 18, 2025

Mar 18, 2025

Creating awareness for Colorectal Cancer Month - WFLA

Mar 18, 2025

Mar 17, 2025

Guardant Accused of Infringing Tempus AI Cancer Research Tech - Bloomberg Law News

Mar 17, 2025

Mar 17, 2025

Guardant Accused of Copying Tempus AI Cancer Research Tech (1) - Bloomberg Law News

Mar 17, 2025

Mar 14, 2025

Liquid biopsy market flooded with opportunity - BioWorld Online

Mar 14, 2025

Mar 14, 2025

Guardant Health rises after Medicare ADLT status for colorectal cancer test - MSN

Mar 14, 2025

Mar 13, 2025

Guardant Health: Great Buy On Dips For Strong Diagnostics Verticals Despite Premium Valuation - Seeking Alpha

Mar 13, 2025

Mar 12, 2025

Guardant Health at Barclays Conference: Strategic Expansion in Diagnostics By Investing.com - Investing.com UK

Mar 12, 2025

Mar 12, 2025

Guardant Health’s ADLT Status Boosts Shield CRC Test’s Market Position and Financial Outlook - TipRanks

Mar 12, 2025